Dweck Associates, Inc. – Trademark Portfolio
Entity Type: 03
Dweck Associates, Inc. has 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ELROSE and ENDLESS BLOOM. The portfolio includes 2 registered trademarks and 3 pending applications. Filings span 5 Nice Classification classes, led by Class 26 (Fancy Goods) and Class 35 (Advertising & Business). This trademark owner is based in New York, NY.
Suite 512
230 5th Avenue
New York, NY 10001
Showing of trademarks Trademarks
Trademark Classifications
Dweck Associates, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Dweck Associates, Inc. have?
Dweck Associates, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending, 6 abandoned, 1 cancelled.
What trademark classes does Dweck Associates, Inc. file in?
Dweck Associates, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 26 (Fancy Goods), Class 35 (Advertising & Business), Class 20 (Furniture), Class 21 (Housewares), Class 16 (Paper Goods). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.
What are Dweck Associates, Inc.'s most well-known trademarks?
Dweck Associates, Inc.'s registered trademark portfolio includes well-known marks such as ELROSE and ENDLESS BLOOM. These are among 2 currently registered trademarks in the portfolio.
What is Dweck Associates, Inc.'s trademark registration success rate?
Dweck Associates, Inc. has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 3 applications are pending review.